Sign in

You're signed outSign in or to get full access.

Dillon

Dillon

Senior Equity Analyst at ROTH Capital Partners

Hartford, CT, US

Dillon is a Senior Equity Analyst at ROTH Capital Partners, specializing in coverage of companies within the technology and healthcare sectors. He closely follows firms such as BioLife Solutions, AeroVironment, and Sientra, and has achieved a TipRanks analyst ranking in the top 20% with a published success rate of above 63% and average returns exceeding 11% per recommendation. Dillon began his investment research career in the mid-2010s, previously holding analyst roles at boutique investment firms before joining ROTH Capital Partners in 2021. He maintains Series 7, 63, and 86 securities licenses, and is recognized for his accurate earnings estimates and contributions to high-profile industry reports.

Dillon's questions to Hut 8 (HUT) leadership

Question · Q3 2025

Dillon asked about the progress in securing long lead time items for the 1.5 GW expansion initiative to improve build time visibility across the four sites.

Answer

CEO Asher Genoot confirmed that all four sites have land control and utility agreements, with power available before development. He noted increased reserves of long lead time items like high-to-medium voltage breakers and a design strategy using common equipment across sites for malleability and risk reduction.

Ask follow-up questions

Fintool

Fintool can predict Hut 8 logo HUT's earnings beat/miss a week before the call